Fasting-mimicking diet to reduce immunotherapy side effects
Part of Cancer, Immune system & allergy clinical trials.
This trial tests whether a special low-calorie 'fasting-mimicking' diet can reduce side effects from common immunotherapy drugs for advanced cancer. If you're on a PD-1, PD-L1, or CTLA-4 inhibitor, this diet might help you feel better during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your body mass index (BMI) is above 19.
- You have advanced (stage 3 or 4) cancer.
- You are getting one of these immunotherapy drugs: nivolumab, pembrolizumab, atezolizumab, avelumab, durvalumab, ipilimumab, or a combination of them.
- You do not use insulin for diabetes.
- You are not pregnant, not nursing, and willing to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study combines a special periodic diet that mimics fasting with the standard immunotherapy drug pembrolizumab (Keytruda) for people with advanced non-small cell lung cancer. The goal is to see if the diet can help the immunotherapy work better.
This trial tests whether a special low-calorie diet that mimics fasting can make chemotherapy more effective for people with hormone-receptor-positive breast cancer. If you qualify, you would follow this diet for a few days before and during your chemo cycles.
This study tests whether periods of fasting (eating very little for set times) combined with immunotherapy drugs might help treat advanced cancers like lung, stomach, liver, or melanoma. The goal is to see if fasting helps the immune-boosting drugs work better.
This study tests if a special diet that mimics fasting can help reduce side effects from hormone therapy (aromatase inhibitors) in women with breast cancer. The diet is a low-calorie meal plan designed to lower cholesterol and improve well-being.
This trial tests if a high-fiber diet and occasional short-term fasting can help melanoma patients respond better to immunotherapy. It aims to improve treatment outcomes by changing gut health.
This trial tests a special 5-day low-calorie, plant-based diet (fasting-mimicking diet) combined with an immunotherapy and a targeted therapy pill for advanced kidney cancer. The goal is to see if this combination improves how well the treatment works.
Hear when a new Advanced Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.